Catalyst Wire Dossier Catalyst Wire Dossier

abacavir/lamivudine

abacavir/lamivudine · GlaxoSmithKline
Drug timelines are a Plus or Pro feature.

8 regulatory and trial events tracked for abacavir/lamivudine, covering 2009-09-15 to 2023-04-18. Get the full timeline:

Most recent: FDA Approved: ABACAVIR AND LAMIVUDINE — Supplemental Application (Aurobindo Pharma Limited)

See pricing